Combination Trastuzumab With Expanded NK Cells for Treating HER2-positive Gastric Cancer
Latest Information Update: 06 Nov 2021
Price :
$35 *
At a glance
- Drugs Natural killer cell therapy (Primary) ; Trastuzumab (Primary)
- Indications Gastric cancer
- Focus Adverse reactions
- 06 Jan 2020 According to ClinicalTrials.gov, the recruitment status of this study is unknown because the information has not been verified recently (last verified June 2016)
- 23 Jun 2016 New trial record